Display options
Share it on

Behav Sci (Basel). 2014 Dec 08;4(4):511-527. doi: 10.3390/bs4040511.

Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP).

Behavioral sciences (Basel, Switzerland)

Boadie W Dunlop, Joanna L Kaye, Cole Youngner, Barbara Rothbaum

Affiliations

  1. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive, 3rd Floor, Atlanta, GA 30329, USA. [email protected].
  2. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive, 3rd Floor, Atlanta, GA 30329, USA. [email protected].
  3. Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA. [email protected].
  4. Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive, 3rd Floor, Atlanta, GA 30329, USA. [email protected].

PMID: 25494488 PMCID: PMC4287702 DOI: 10.3390/bs4040511

Abstract

Patients with posttraumatic stress disorder (PTSD) who fail to respond to established treatments are at risk for chronic disability and distress. Although treatment-resistant PTSD (TR-PTSD) is a common clinical problem, there is currently no standard method for evaluating previous treatment outcomes. Development of a tool that could quantify the degree of resistance to previously provided treatments would inform research in patients with PTSD. We conducted a systematic review of PTSD treatment trials to identify medication and psychotherapy interventions proven to be efficacious for PTSD. We then developed a semi-structured clinician interview called the Emory Treatment Resistance Interview for PTSD (E-TRIP). The E-TRIP includes clinician-administered questions to assess the adequacy and benefit derived from past treatment trials. For each adequately delivered treatment to which the patient failed to respond, a score is assigned depending on the strength of evidence supporting the treatment's efficacy. The E-TRIP provides a comprehensive assessment of prior PTSD treatments that should prove valuable for researchers studying TR-PTSD and evaluating the efficacy of new treatments for patients with PTSD. The E-TRIP is not intended to guide treatment; rather, the tool quantifies the level of treatment resistance in patients with PTSD in order to standardize TR-PTSD in the research domain.

References

  1. J Clin Psychiatry. 2002 Mar;63(3):199-206 - PubMed
  2. Br J Psychiatry. 1999 Jul;175:17-22 - PubMed
  3. J Rehabil Res Dev. 2012;49(5):649-65 - PubMed
  4. J Clin Psychiatry. 2001 Nov;62(11):860-8 - PubMed
  5. BMJ. 2007 Jun 2;334(7604):1147 - PubMed
  6. Biol Psychiatry. 2003 Apr 15;53(8):649-59 - PubMed
  7. J Consult Clin Psychol. 2006 Oct;74(5):898-907 - PubMed
  8. Mil Med. 2012 Sep;177(9):1015-21 - PubMed
  9. J Consult Clin Psychol. 2004 Feb;72(1):3-18 - PubMed
  10. Am J Psychiatry. 2013 Sep;170(9):1003-10 - PubMed
  11. J Clin Psychiatry. 2009 Feb;70(2):177-84 - PubMed
  12. JAMA. 2012 Aug 15;308(7):700-9 - PubMed
  13. Am J Psychiatry. 2007 Nov;164(11):1676-83 - PubMed
  14. Depress Anxiety. 2011 Jul;28(7):541-50 - PubMed
  15. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65 - PubMed
  16. Depress Anxiety. 2007;24(2):77-84 - PubMed
  17. Behav Res Ther. 1996 Aug;34(8):669-73 - PubMed
  18. Am J Psychiatry. 2012 Jan;169(1):80-8 - PubMed
  19. J Nerv Ment Dis. 2007 Jun;195(6):504-13 - PubMed
  20. N Engl J Med. 2005 Aug 4;353(5):487-97 - PubMed
  21. BMC Psychiatry. 2007 Apr 19;7:13 - PubMed
  22. Am J Psychiatry. 2001 Dec;158(12):1982-8 - PubMed
  23. JAMA. 2007 Feb 28;297(8):820-30 - PubMed
  24. J Nerv Ment Dis. 2013 Feb;201(2):153-60 - PubMed
  25. J Consult Clin Psychol. 2002 Aug;70(4):867-79 - PubMed
  26. Biol Psychiatry. 2005 Mar 1;57(5):474-9 - PubMed
  27. J Trauma Stress. 2010 Oct;23(5):537-52 - PubMed
  28. J Consult Clin Psychol. 2005 Oct;73(5):953-64 - PubMed
  29. J Clin Psychiatry. 2011 Jul;72(7):892-7 - PubMed
  30. J Consult Clin Psychol. 2008 Apr;76(2):259-71 - PubMed
  31. J Consult Clin Psychol. 1999 Apr;67(2):194-200 - PubMed
  32. J Consult Clin Psychol. 2013 Aug;81(4):639-49 - PubMed
  33. Am J Psychiatry. 2004 Nov;161(11 Suppl):3-31 - PubMed
  34. JAMA. 2013 Aug 7;310(5):488-95 - PubMed
  35. J Psychosom Res. 2011 Apr;70(4):335-45 - PubMed
  36. Psychother Res. 2008 Sep;18(5):497-507 - PubMed
  37. Arch Gen Psychiatry. 2003 May;60(5):481-9 - PubMed
  38. CNS Spectr. 2004 Oct;9(10):740-52 - PubMed
  39. J Nerv Ment Dis. 1991 Jun;179(6):366-70 - PubMed
  40. Arch Gen Psychiatry. 2003 Oct;60(10):1024-32 - PubMed
  41. J Trauma Stress. 2005 Dec;18(6):607-16 - PubMed
  42. J Tradit Chin Med. 2011 Mar;31(1):60-3 - PubMed
  43. Psychol Med. 2011 Oct;41(10):2159-66 - PubMed
  44. AIDS Behav. 2012 Jul;16(5):1327-40 - PubMed
  45. Int J Neuropsychopharmacol. 2012 Jul;15(6):825-40 - PubMed
  46. Arch Gen Psychiatry. 2001 May;58(5):485-92 - PubMed
  47. Psychol Med. 1997 Jan;27(1):153-60 - PubMed
  48. Soc Psychiatry Psychiatr Epidemiol. 2010 Jan;45(1):47-56 - PubMed
  49. J Trauma Stress. 2011 Oct;24(5):591-5 - PubMed
  50. J Consult Clin Psychol. 2002 Oct;70(5):1067-74 - PubMed
  51. JAMA. 2012 Aug 15;308(7):690-9 - PubMed
  52. J Trauma Stress. 1995 Jan;8(1):75-90 - PubMed
  53. J Clin Psychopharmacol. 2004 Jun;24(3):291-7 - PubMed
  54. Ann Pharmacother. 2009 Jul;43(7):1227-32 - PubMed
  55. J Clin Psychiatry. 2012 Dec;73(12):1503-8 - PubMed
  56. Am J Psychiatry. 2003 Feb;160(2):371-3 - PubMed
  57. Psychother Psychosom. 2008;77(2):101-10 - PubMed
  58. JAMA. 2000 Apr 12;283(14):1837-44 - PubMed
  59. J Trauma Stress. 2003 Feb;16(1):81-91 - PubMed
  60. Control Clin Trials. 2000 Jun;21(3):167-89 - PubMed
  61. J Anxiety Disord. 2012 Apr;26(3):442-52 - PubMed
  62. J Clin Psychopharmacol. 2006 Jun;26(3):259-67 - PubMed
  63. Br J Psychiatry. 2002 Oct;181:315-20 - PubMed
  64. J Consult Clin Psychol. 2005 Oct;73(5):965-71 - PubMed
  65. J Clin Psychiatry. 2011 Aug;72(8):1152-4 - PubMed

Publication Types

Grant support